Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Wearable Device Could Help Diagnose Sleep Apnea after Traumatic Brain Injury

XTALKS VITALS NEWS

Wearable Device

Patients may feel more comfortable undergoing sleep testing in their own home, allowing clinicians to more accurately diagnose the sleep disorder and commence treatment.

Share this!

April 19, 2017 | by Sarah Hand, M.Sc.

Could a wearable device be just as effective as a sleep clinic at diagnosing sleep apnea following traumatic brain injury? This is the question that researchers from the University of Texas (UT) Southwestern Medical Center aim to answer in an upcoming national study.

If the wristwatch-like devices, which measure sleep and wake cycles through actigraphy, are capable of producing data comparable to that generated from lab-based sleep studies, known as polysomnography, they may provide an easier way to diagnose sleep apnea. Patients may feel more comfortable undergoing sleep testing in their own home, allowing clinicians to more accurately diagnose the sleep disorder and commence treatment.

It’s estimated that sleep apnea affects one in every 15 individuals in the US. The condition, characterized by snoring and interruptions in breathing that make it difficult for people to get sufficient rest, becomes even more problematic in patients with a traumatic brain injury.

“Optimizing sleep is essential for neurorecovery after traumatic brain injury,” said Dr. Kathleen Bell, the project’s investigator at the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center and Chair of Physical Medicine and Rehabilitation. If sleep apnea goes undiagnosed in these patients, it could present a major hurdle to complete recovery.



Bell and her team recently published a study on the incidence of sleep apnea among patients who were admitted to brain injury rehabilitation centers multiple times. About half of all patients admitted to brain rehab – 37 percent of which had suffered a traumatic brain injury – had also been diagnosed with sleep apnea.

Despite the fact that approximately three million people experience a traumatic brain injury each year, these patients often don’t realize that they are at a higher risk of developing sleep apnea. If the wrist actigraphs being tested in the current study show promise, they could offer a simple way of monitoring sleep patterns in patients after they have experienced head trauma.

“We know that you can identify disturbances in sleep with wrist actigraphs,” said Bell. “What we don’t know is how effective these screening methods are stacked up against one another.”

The study will be funded through a $2.68 million grant from the Patient-Centered Outcomes Research Institute (PCORI). Bell and her team will commence enrollment for the multi-center study next month using patients from Traumatic Brain Injury Model System Research Centers across the US.


Keywords:  Wearable Device, Sleep Apnea, Traumatic Brain Injury


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Early Alzheimer’s Patients May See Benefit from Anti-Epilepsy Drug

June 27, 2017 - While the processes behind Alzheimer’s disease development aren’t fully understood, recent research has suggested that some cognitive decline could be caused by seizure-like activity in the brains of patients.

Featured In: Clinical Trials News


First Human Colon Organoids Grown in Lab

June 26, 2017 - Using human pluripotent stem cells, researchers at Cincinnati Children's Hospital Medical Center have developed colon-like organoids that can be transplanted into mice.

Featured In: Life Science News


Could Genetic Markers Help Identify Patients at Risk of Opioid Overdose?

June 26, 2017 - Researchers at Erasmus University Medical Center in the Netherlands have identified 10 genes which may help healthcare providers predict which patients could respond poorly to opioid medications.

Featured In: Drug Safety News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Drug Development During the Last Week

REGISTER FOR THESE WEBINARS

Serialized? Yes. But are Products Still Being Diverted?


Quantitative Protein Profiling in FFPE to Characterize Toxicities Associated with Immune Checkpoint Inhibitors


Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model


Imaging-based Subtypes of Pancreatic Cancer


Copyright © 2016-2017 Honeycomb Worldwide Inc.